Form 4: Korro Bio Insider Buys $56 Worth of Common Stock

Paul Edward Walker, a director of Korro Bio, Inc., indirectly acquired 17,857 shares of common stock at $56 per share on April 22, 2024, through a transaction related to a Subscription Agreement.

Summary

• On April 22, 2024, Paul Edward Walker, a director of Korro Bio, Inc., acquired 17,857 shares of common stock at a price of $56 per share.
• The acquisition was made indirectly through NEA 17, where Walker is a manager of NEA 17 GP, LLC, the sole general partner of NEA Partners 17, L.P., which in turn is the sole general partner of New Enterprise Associates 17, L.P. (NEA 17).
• The transaction was executed pursuant to a Subscription Agreement dated April 17, 2024.
• Following the transaction, Walker indirectly owns 1,090,793 shares.
• Walker disclaims beneficial ownership of the securities held by NEA 17, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports an insider transaction, which could be interpreted in various ways depending on the broader context.

Positives

• Insider buying can sometimes be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction may have a minor impact on shareholder sentiment, depending on how it's perceived by the market.

Key Dates